Sitaxsentan and Sildenafil

DRUG2 trials

Sponsors

Pfizer

Conditions

Pulmonary Arterial HypertensionPulmonary Hypertension

Phase 3

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

TerminatedNCT00796666

PfizerPulmonary Arterial Hypertension, Pulmonary Hypertension

Start: 2009-05-31End: 2011-03-31Updated: 2015-03-24

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

TerminatedNCT00796510

PfizerPulmonary Arterial Hypertension, Pulmonary Hypertension

Start: 2010-07-31End: 2011-01-31Updated: 2018-10-25